Organization

GENIALIS D.O.O

Slovenian bioinformatics SME building genomics data analysis platforms with interactive visualizations for life science research.

Technology SMEdigitalSISMENo active H2020 projectsThin data (2/5)

H2020 projects

As coordinator

Total EC funding

€807K

Unique partners

What they do

Their core work

Genialis is a Slovenian bioinformatics SME that builds data analysis platforms for genomics and life sciences. Their core product centers on interactive visualization pipelines for genomic data, enabling researchers to process and interpret complex biological datasets without deep programming expertise. They apply these capabilities across domains — from vaccine immunology monitoring to computational design of microbial cell factories — positioning themselves as a software infrastructure provider for data-intensive life science research.

Core expertise

What they specialise in

Genomics data analysis platformsprimary

2 projects

Coordinated GDAPIV (Genomics Data Analysis Pipelines with Interactive Visualizations) and contributed bioinformatics services to DD-DeCaF.

Bioinformatics for synthetic biologysecondary

1 project

Participated in DD-DeCaF, providing data-driven design tools for cell factories and microbial communities.

Population health data analyticssecondary

1 project

Contributed to Vaccinesurvey for monitoring population immunity against vaccine-preventable diseases.

Interactive data visualizationprimary

2 projects

GDAPIV was explicitly focused on interactive visualizations; this capability likely underpins their contributions to DD-DeCaF as well.

Evolution & trajectory

How they've shifted over time

Early focus

Genomics pipeline development

Recent focus

Applied bioinformatics services

All three projects fall within the 2015-2020 window with significant overlap, making it difficult to identify a strong temporal shift. Their earliest activity (2015) included both a feasibility study for their own genomics platform (GDAPIV, SME Phase 1) and joining a vaccine immunity consortium. By 2016 they moved into synthetic biology bioinformatics with DD-DeCaF, suggesting a broadening from pure genomics pipelines toward applied biological data services.

Genialis appears to be evolving from a genomics toolmaker into a broader bioinformatics service provider, applying their platform capabilities to diverse life science domains like synthetic biology and public health.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European10 countries collaborated

Genialis operates primarily as a specialist partner, joining consortia (2 of 3 projects) rather than leading them. Their one coordination role was an SME Phase 1 feasibility study — a solo instrument — so their consortium leadership experience is limited. With 16 unique partners across 10 countries from just 3 projects, they integrate comfortably into mid-sized international teams and bring a specific technical capability rather than driving the research agenda.

Despite only three projects, Genialis has built a surprisingly broad network of 16 partners across 10 countries, reflecting the international nature of the consortia they joined. No strong geographic concentration is visible — they appear comfortable collaborating across Europe.

Why partner with them

What sets them apart

Genialis occupies an uncommon niche as a Slovenian SME specializing in bioinformatics platform development — most such companies cluster in the UK, Netherlands, or Germany. Their strength is translating raw genomic and biological data into accessible, visual, analyst-friendly formats. For consortium builders, they offer a compact, agile software team that can plug bioinformatics infrastructure into projects spanning health, biotech, and synthetic biology.

Notable projects

Highlights from their portfolio

DD-DeCaF
Largest project by funding (EUR 536,875 to Genialis) focused on computational design of cell factories — an intersection of bioinformatics and industrial biotechnology.
GDAPIV
Their own SME Phase 1 feasibility study for genomics visualization pipelines, revealing their core product ambition and entrepreneurial drive.

Cross-sector capabilities

Health and vaccine monitoringIndustrial biotechnology and synthetic biologyAgricultural and food biotechnologyPharmaceutical R&D data infrastructure

Analysis note: Profile based on only 3 projects with no keyword metadata. The project titles and descriptions are informative enough to establish a clear bioinformatics focus, but the small sample size means this profile may not capture the full scope of Genialis's capabilities. No website URL was available for verification.